Cargando…

The role of tumor metabolism as a driver of prostate cancer progression and lethal disease: results from a nested case-control study

BACKGROUND: Understanding the biologic mechanisms underlying the development of lethal prostate cancer is critical for improved therapeutic and prevention strategies. In this study we explored the role of tumor metabolism in prostate cancer progression using mRNA expression profiling of seven metabo...

Descripción completa

Detalles Bibliográficos
Autores principales: Kelly, Rachel S., Sinnott, Jennifer A., Rider, Jennifer R., Ebot, Ericka M., Gerke, Travis, Bowden, Michaela, Pettersson, Andreas, Loda, Massimo, Sesso, Howard D., Kantoff, Philip W., Martin, Neil E., Giovannucci, Edward L., Tyekucheva, Svitlana, Heiden, Matthew Vander, Mucci, Lorelei A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5142400/
https://www.ncbi.nlm.nih.gov/pubmed/27980733
http://dx.doi.org/10.1186/s40170-016-0161-9
_version_ 1782472768138248192
author Kelly, Rachel S.
Sinnott, Jennifer A.
Rider, Jennifer R.
Ebot, Ericka M.
Gerke, Travis
Bowden, Michaela
Pettersson, Andreas
Loda, Massimo
Sesso, Howard D.
Kantoff, Philip W.
Martin, Neil E.
Giovannucci, Edward L.
Tyekucheva, Svitlana
Heiden, Matthew Vander
Mucci, Lorelei A.
author_facet Kelly, Rachel S.
Sinnott, Jennifer A.
Rider, Jennifer R.
Ebot, Ericka M.
Gerke, Travis
Bowden, Michaela
Pettersson, Andreas
Loda, Massimo
Sesso, Howard D.
Kantoff, Philip W.
Martin, Neil E.
Giovannucci, Edward L.
Tyekucheva, Svitlana
Heiden, Matthew Vander
Mucci, Lorelei A.
author_sort Kelly, Rachel S.
collection PubMed
description BACKGROUND: Understanding the biologic mechanisms underlying the development of lethal prostate cancer is critical for improved therapeutic and prevention strategies. In this study we explored the role of tumor metabolism in prostate cancer progression using mRNA expression profiling of seven metabolic pathways; fatty acid metabolism, glycolysis/gluconeogenesis, oxidative phosphorylation, pentose phosphate, purine metabolism, pyrimidine metabolism and the tricarboxylic acid cycle. METHODS: The study included 404 men with archival formalin-fixed, paraffin-embedded prostate tumor tissue from the prospective Health Professionals Follow-up Study and Physicians’ Health Study. Lethal cases (n = 113) were men who experienced a distant metastatic event or died of prostate cancer during follow-up. Non-lethal controls (n = 291) survived at least 8 years post-diagnosis without metastases. Of 404 men, 202 additionally had matched normal tissue (140 non-lethal, 62 lethal). Analyses compared expression levels between tumor and normal tissue, by Gleason grade and by lethal status. Secondary analyses considered the association with biomarkers of cell proliferation, apoptosis and angiogenesis. RESULTS: Oxidative phosphorylation and pyrimidine metabolism were identified as the most dysregulated pathways in lethal tumors (p < 0.007), and within these pathways, a number of novel differentially expressed genes were identified including POLR2K and APT6V1A. The associations were tumor specific as there was no evidence any pathways were altered in the normal tissue of lethal compared to non-lethal cases. CONCLUSIONS: The results suggest prostate cancer progression and lethal disease are associated with alterations in key metabolic signaling pathways. Pathways supporting proliferation appeared to be of particular importance in prostate tumor aggressiveness. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s40170-016-0161-9) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-5142400
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-51424002016-12-15 The role of tumor metabolism as a driver of prostate cancer progression and lethal disease: results from a nested case-control study Kelly, Rachel S. Sinnott, Jennifer A. Rider, Jennifer R. Ebot, Ericka M. Gerke, Travis Bowden, Michaela Pettersson, Andreas Loda, Massimo Sesso, Howard D. Kantoff, Philip W. Martin, Neil E. Giovannucci, Edward L. Tyekucheva, Svitlana Heiden, Matthew Vander Mucci, Lorelei A. Cancer Metab Research BACKGROUND: Understanding the biologic mechanisms underlying the development of lethal prostate cancer is critical for improved therapeutic and prevention strategies. In this study we explored the role of tumor metabolism in prostate cancer progression using mRNA expression profiling of seven metabolic pathways; fatty acid metabolism, glycolysis/gluconeogenesis, oxidative phosphorylation, pentose phosphate, purine metabolism, pyrimidine metabolism and the tricarboxylic acid cycle. METHODS: The study included 404 men with archival formalin-fixed, paraffin-embedded prostate tumor tissue from the prospective Health Professionals Follow-up Study and Physicians’ Health Study. Lethal cases (n = 113) were men who experienced a distant metastatic event or died of prostate cancer during follow-up. Non-lethal controls (n = 291) survived at least 8 years post-diagnosis without metastases. Of 404 men, 202 additionally had matched normal tissue (140 non-lethal, 62 lethal). Analyses compared expression levels between tumor and normal tissue, by Gleason grade and by lethal status. Secondary analyses considered the association with biomarkers of cell proliferation, apoptosis and angiogenesis. RESULTS: Oxidative phosphorylation and pyrimidine metabolism were identified as the most dysregulated pathways in lethal tumors (p < 0.007), and within these pathways, a number of novel differentially expressed genes were identified including POLR2K and APT6V1A. The associations were tumor specific as there was no evidence any pathways were altered in the normal tissue of lethal compared to non-lethal cases. CONCLUSIONS: The results suggest prostate cancer progression and lethal disease are associated with alterations in key metabolic signaling pathways. Pathways supporting proliferation appeared to be of particular importance in prostate tumor aggressiveness. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s40170-016-0161-9) contains supplementary material, which is available to authorized users. BioMed Central 2016-12-07 /pmc/articles/PMC5142400/ /pubmed/27980733 http://dx.doi.org/10.1186/s40170-016-0161-9 Text en © The Author(s). 2016 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Kelly, Rachel S.
Sinnott, Jennifer A.
Rider, Jennifer R.
Ebot, Ericka M.
Gerke, Travis
Bowden, Michaela
Pettersson, Andreas
Loda, Massimo
Sesso, Howard D.
Kantoff, Philip W.
Martin, Neil E.
Giovannucci, Edward L.
Tyekucheva, Svitlana
Heiden, Matthew Vander
Mucci, Lorelei A.
The role of tumor metabolism as a driver of prostate cancer progression and lethal disease: results from a nested case-control study
title The role of tumor metabolism as a driver of prostate cancer progression and lethal disease: results from a nested case-control study
title_full The role of tumor metabolism as a driver of prostate cancer progression and lethal disease: results from a nested case-control study
title_fullStr The role of tumor metabolism as a driver of prostate cancer progression and lethal disease: results from a nested case-control study
title_full_unstemmed The role of tumor metabolism as a driver of prostate cancer progression and lethal disease: results from a nested case-control study
title_short The role of tumor metabolism as a driver of prostate cancer progression and lethal disease: results from a nested case-control study
title_sort role of tumor metabolism as a driver of prostate cancer progression and lethal disease: results from a nested case-control study
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5142400/
https://www.ncbi.nlm.nih.gov/pubmed/27980733
http://dx.doi.org/10.1186/s40170-016-0161-9
work_keys_str_mv AT kellyrachels theroleoftumormetabolismasadriverofprostatecancerprogressionandlethaldiseaseresultsfromanestedcasecontrolstudy
AT sinnottjennifera theroleoftumormetabolismasadriverofprostatecancerprogressionandlethaldiseaseresultsfromanestedcasecontrolstudy
AT riderjenniferr theroleoftumormetabolismasadriverofprostatecancerprogressionandlethaldiseaseresultsfromanestedcasecontrolstudy
AT eboterickam theroleoftumormetabolismasadriverofprostatecancerprogressionandlethaldiseaseresultsfromanestedcasecontrolstudy
AT gerketravis theroleoftumormetabolismasadriverofprostatecancerprogressionandlethaldiseaseresultsfromanestedcasecontrolstudy
AT bowdenmichaela theroleoftumormetabolismasadriverofprostatecancerprogressionandlethaldiseaseresultsfromanestedcasecontrolstudy
AT petterssonandreas theroleoftumormetabolismasadriverofprostatecancerprogressionandlethaldiseaseresultsfromanestedcasecontrolstudy
AT lodamassimo theroleoftumormetabolismasadriverofprostatecancerprogressionandlethaldiseaseresultsfromanestedcasecontrolstudy
AT sessohowardd theroleoftumormetabolismasadriverofprostatecancerprogressionandlethaldiseaseresultsfromanestedcasecontrolstudy
AT kantoffphilipw theroleoftumormetabolismasadriverofprostatecancerprogressionandlethaldiseaseresultsfromanestedcasecontrolstudy
AT martinneile theroleoftumormetabolismasadriverofprostatecancerprogressionandlethaldiseaseresultsfromanestedcasecontrolstudy
AT giovannucciedwardl theroleoftumormetabolismasadriverofprostatecancerprogressionandlethaldiseaseresultsfromanestedcasecontrolstudy
AT tyekuchevasvitlana theroleoftumormetabolismasadriverofprostatecancerprogressionandlethaldiseaseresultsfromanestedcasecontrolstudy
AT heidenmatthewvander theroleoftumormetabolismasadriverofprostatecancerprogressionandlethaldiseaseresultsfromanestedcasecontrolstudy
AT mucciloreleia theroleoftumormetabolismasadriverofprostatecancerprogressionandlethaldiseaseresultsfromanestedcasecontrolstudy
AT kellyrachels roleoftumormetabolismasadriverofprostatecancerprogressionandlethaldiseaseresultsfromanestedcasecontrolstudy
AT sinnottjennifera roleoftumormetabolismasadriverofprostatecancerprogressionandlethaldiseaseresultsfromanestedcasecontrolstudy
AT riderjenniferr roleoftumormetabolismasadriverofprostatecancerprogressionandlethaldiseaseresultsfromanestedcasecontrolstudy
AT eboterickam roleoftumormetabolismasadriverofprostatecancerprogressionandlethaldiseaseresultsfromanestedcasecontrolstudy
AT gerketravis roleoftumormetabolismasadriverofprostatecancerprogressionandlethaldiseaseresultsfromanestedcasecontrolstudy
AT bowdenmichaela roleoftumormetabolismasadriverofprostatecancerprogressionandlethaldiseaseresultsfromanestedcasecontrolstudy
AT petterssonandreas roleoftumormetabolismasadriverofprostatecancerprogressionandlethaldiseaseresultsfromanestedcasecontrolstudy
AT lodamassimo roleoftumormetabolismasadriverofprostatecancerprogressionandlethaldiseaseresultsfromanestedcasecontrolstudy
AT sessohowardd roleoftumormetabolismasadriverofprostatecancerprogressionandlethaldiseaseresultsfromanestedcasecontrolstudy
AT kantoffphilipw roleoftumormetabolismasadriverofprostatecancerprogressionandlethaldiseaseresultsfromanestedcasecontrolstudy
AT martinneile roleoftumormetabolismasadriverofprostatecancerprogressionandlethaldiseaseresultsfromanestedcasecontrolstudy
AT giovannucciedwardl roleoftumormetabolismasadriverofprostatecancerprogressionandlethaldiseaseresultsfromanestedcasecontrolstudy
AT tyekuchevasvitlana roleoftumormetabolismasadriverofprostatecancerprogressionandlethaldiseaseresultsfromanestedcasecontrolstudy
AT heidenmatthewvander roleoftumormetabolismasadriverofprostatecancerprogressionandlethaldiseaseresultsfromanestedcasecontrolstudy
AT mucciloreleia roleoftumormetabolismasadriverofprostatecancerprogressionandlethaldiseaseresultsfromanestedcasecontrolstudy